Sumatriptan Succinate
Brand name: Sumatriptan Succinate
Rank #428 of 500 drugs by total cost
$19.4M
Total Cost
555,011
Total Claims
$19.4M
Total Cost
24,335
Prescribers
$35
Cost per Claim
29,581
Beneficiaries
643,420
30-Day Fills
$798
Avg Cost/Provider
23
Avg Claims/Provider
About Sumatriptan Succinate
Sumatriptan Succinate (sold as Sumatriptan Succinate) was prescribed 555,011 times by 24,335 Medicare Part D providers in 2023, costing the program $19.4M. At $35 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 425 | Clobazam (Clobazam) | $19.8M | 58,877 |
| 426 | Fluorouracil (Fluorouracil) | $19.5M | 220,445 |
| 427 | Ertapenem Sodium (Ertapenem) | $19.4M | 36,784 |
| 428 | Sumatriptan Succinate (Sumatriptan Succinate) | $19.4M | 555,011 |
| 429 | Darbepoetin Alfa In Polysorbat (Aranesp) | $19.3M | 6,889 |
| 430 | Ondansetron Hcl (Ondansetron Hcl) | $19.3M | 1,255,548 |
| 431 | Tasimelteon (Hetlioz) | $19.3M | 763 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology